The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Progenics
Leadership - Progenics
Stock and Other Ownership Interests - Progenics
Long-term survival and safety from a multi-center, open-label, pivotal phase 2 study of iobenguane I 131 in patients (Pts) with unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL).
 
Richard B. Noto
Consulting or Advisory Role - Progenics
Research Funding - Progenics (Inst)
 
Camilo Jimenez
Research Funding - Progenics (Inst)
 
Bennett B. Chin
Consulting or Advisory Role - Progenics
Research Funding - Progenics (Inst)
 
Joseph S. Dillon
Research Funding - Lexicon (Inst); Progenics (Inst)
 
Lilja Solnes
Research Funding - Progenics (Inst)
 
Vincent A. DiPippo
Employment - Progenics
Stock and Other Ownership Interests - Progenics
 
Syed Mahmood
Employment - Progenics
Leadership - Progenics
Stock and Other Ownership Interests - Progenics
 
Nancy Stambler
Employment - Progenics
Stock and Other Ownership Interests - Progenics
 
Tess Lin
Employment - Progenics
Stock and Other Ownership Interests - Progenics
 
Jessica Donato Jensen
No Relationships to Disclose
 
Vivien Wong
Employment - Progenics
Leadership - Progenics
Stock and Other Ownership Interests - Progenics
 
Daniel A. Pryma
Consulting or Advisory Role - Actinium Pharmaceuticals; FivePhusion; Nordic Nanovector; Progenics
Research Funding - FivePhusion (Inst); Progenics (Inst); Siemens (Inst)